Furthermore, ALS/FTD patients exhibit splicing alterations in several key targets and insoluble hnRNP H, indicating that modifications along this axis are critical aspects of disease etiology [52]. The gene discussed is HNRNPH2; the disease is amyotrophic lateral sclerosis.